Clinical Trial

A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold

Name: A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold — clinical trial record (NCT06697886)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated November 20, 2024 (before its estimated June 25, 2025 completion). Its status may not reflect the trial's current state.

Summary

To further evaluate the efficacy and safety of Antiwei granule in the treatment of common cold (wind-cold syndrome)

Trial Details

NCT Number	NCT06697886
Lead Sponsor	Tasly Pharmaceutical Group Co., Ltd
Conditions	Common Cold
Enrollment	480 participants
Start Date	2023-11-16
Primary Completion	2025-06-25 (estimated)
Study Completion	2025-07-01 (estimated)
Updated on ClinicalTrials.gov	2024-11-20